Indeed, using the E6 medium, an iPSC line SM14, derived from a preclinical PD patient with compound heterozygous loss-of-function mutations in PARK2 linked to familial early-onset PD, was successfully differentiated into BMECs. Here, PRKN is linked to Parkinson disease.